01 9ASTRAZENECA AB
01 99616028
01 9Blank
01 9Y
01 92030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
Patent Expiration Date : 2030-11-12
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9616028
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-12
